GURUFOCUS.COM » STOCK LIST » Oceania » Australia » ASX » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Total Stockholders Equity
Switch to:

Vectus Biosystems (ASX:VBS) Total Stockholders Equity

: A$4.83 Mil (As of Dec. 2022)
View and export this data going back to 2016. Start your Free Trial

Vectus Biosystems's Total Stockholders Equity for the quarter that ended in Dec. 2022 was A$4.83 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Vectus Biosystems's Book Value per Share for the quarter that ended in Dec. 2022 was A$0.09. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Vectus Biosystems's Debt-to-Equity for the quarter that ended in Dec. 2022 was 0.00.


Vectus Biosystems Total Stockholders Equity Historical Data

The historical data trend for Vectus Biosystems's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Total Stockholders Equity
Premium Member Only Premium Member Only -2.26 -3.73 -5.65 -2.82 -3.53

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Total Stockholders Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.70 -2.82 -4.92 -3.53 4.83

Vectus Biosystems  (ASX:VBS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Vectus Biosystems's Book Value per Share for the quarter that ended in Dec. 2022 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Vectus Biosystems's Debt-to-Equity for the quarter that ended in Dec. 2022 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vectus Biosystems Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems (ASX:VBS) Business Description

Vectus Biosystems logo
Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines